- Home
- PRTS vs FLNA Comparison
PRTS vs FLNA Comparison
Compare PRTS & FLNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRTS | FLNA |
|---|---|---|
| Founded | 1995 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto & Home Supply Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.7M | 61.8M |
| IPO Year | 2006 | 2000 |
Fundamental Metrics
Financial Performance| Metric | PRTS | FLNA |
|---|---|---|
| Price | $9.36 | $0.82 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $0.50 | N/A |
| AVG Volume (30 Days) | 32.2K | ★ 251.9K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $41,119,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.25 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.37 | $0.82 |
| 52 Week High | $8.80 | $2.03 |
Technical Indicators
Market Signals| Indicator | PRTS | FLNA |
|---|---|---|
| Relative Strength Index (RSI) | 76.74 | 33.69 |
| Support Level | $0.53 | N/A |
| Resistance Level | N/A | $0.99 |
| Average True Range (ATR) | 0.50 | 0.05 |
| MACD | 0.16 | -0.00 |
| Stochastic Oscillator | 77.52 | 7.54 |
Price Performance
Historical ComparisonAbout PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. Its products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
About FLNA Filana Therapeutics Inc. Common Stock
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.